|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/42 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 37/08 | (2006.01) |
| (11) | Number of the document | 3190128 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16170993.6 |
| Date of filing the European patent application | 2009-09-17 | |
| (97) | Date of publication of the European application | 2017-07-12 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-14 |
| (46) | Date of publication of the claims translation | 2019-01-10 |
| (30) | Number | Date | Country code |
| 97819 P | 2008-09-17 | US |
| (72) |
DESJARLAIS, John R., US
CHU, Seung Y., US
HORTON, Holly M., US
|
| (73) |
Xencor, Inc.,
111 W. Lemon Avenue, Monrovia, CA 91016,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kompozicijos ir būdai, skirti IgE sukeltų sutrikimų gydymui |
| COMPOSITIONS AND METHODS FOR TREATING IGE-MEDIATED DISORDERS |
| Payment date | Validity (years) | Amount | |
| 2025-09-03 | 17 | 347.00 EUR |
| 2026-09-17 |